Street:18 Jinlong Road, Weicun Jiangbian Industry Zone, Chunjiang Town,Xinbei District, Changzhou City, Jiangsu Province, P. R. China
MaxCard:
About us
Welcome To Our Site!
Changzhou Yabang-QH Pharmachem Co., Ltd. (shortly called as Yabang-QH) is a Sino-US Joint Venture professionally specialized in R&D, manufacturing, sales and marketing of Anthelmintic products. The company currently owns three manufacturing factories, i.e. Changzhou Yabang Veterinary Co., Ltd. located in the south suburb of Changzhou City, Changzhou Yabang-QH Pharmachem Co., Ltd. located in the "Pharmaceutical Industrial Base" in Changzhou Xinbei District (The Sate Spark Program), and Lianyungang City Yahui Pharmachem Co., Ltd. located in Jiangsu Lianyungang Chemical Industry Park.
The company already obtained ISO9001 Certificate issued by Lloyd's Register Quality Assurance UK and Chinese GMP Certificate. We obtained the authentication on ISO14001 Environmental Protection Management System and OSHAS18001 EHS System. The company was awarded a lot of honors, such as "Hi-tech Enterprise in Jiangsu Province", "The Top Fifty Veterinary Enterprises in China", "Advanced Clean Production Enterprise" and "Enterprise with Great Science & Technology Progress".
In order to expedite the R&D speed for the new products, the company set up its own R&D center and Kilo-labs. We also jointly founded Changzhou City Veterinary Engineering & Technology Center with the local government, specializing in the R&D of Anthelmintic Products. We also closely cooperate with several Chinese Scientific Research Institutes, and now working on several "Jiangsu Provincial Science & Technology Innovation Projects" and "State Spark Program Projects". The company now has strong R&D capability.
The company is specialized in manufacturing of Anthelmintic Products with the largest capabilities and categories in China now. Besides,Biological Buffers and other high value-added products are developed. While we are striving to be the biggest professional Anthelmintic products manufacturing base in the world, the company is actively developing other new products so as to obtain diversified growing. Our products sell well all over China, and 80% of our turnover is made by self-exporting to more than 100 countries. While we are aggressively maintaining the current domestic and international markets, we also increased our input on regulatory markets development, upgrading cGMP management level, expedite EHS authentication and product regulatory registrations. We already built very close cooperation relationship with some famous multinational drug companies. Welcome existing and potential clients to visit our company for mutual development.